Skip to main content

Table 3 Pre- and postoperative hemodynamic data (cMRI)

From: Right ventricular remodeling after conduit replacement in patients with corrected tetralogy of Fallot - evaluation by cardiac magnetic resonance

Variables (n = 10) Before PVR After PVR Students t-test Wilcoxon Signed Rank Test
RVEDV (ml) 309 ± 85 231 ± 45 0.001 0.005
RVEDVI (ml/m2) 161 ± 33 120 ± 23 < 0.001 0.005
RVESV (ml) 171 ± 58 136 ± 40 0.043 0.047
RVESVI (ml/m2) 89 ± 25 71 ± 21 0.036 0.047
RVSV (ml) 138 ± 45 95 ± 13 0.006 0.005
RVSVI (ml/m2) 72 ± 20 50 ± 6 0.002 0.005
RVEF (%) 46 ± 11 42 ± 9 0.337 0.373
LVEDV (ml) 149 ± 22 171 ± 28 0.002 0.007
LVEDVI (ml/m2) 79 ± 10 90 ± 15 0.012 0.015
LVESV (ml) 68 ± 17 76 ± 20 0.213 0.236
LVESVI (ml/m2) 36 ± 8 40 ± 11 0.271 0.284
LVSV (ml) 81 ± 12 95 ± 12 < 0.001 0.005
LVSVI (ml/m2) 43 ± 7 50 ± 6 0.001 0.005
LVEF (%) 55 ± 7 56 ± 6 0.656 0.593
PI (%) 49 ± 11 1 ± 1 < 0.001 NA
MPA netflow (mL/min) 5100 ± 1500 6100 ± 800 0.120 0.139
  1. Values are expressed as number (%) or mean ± SD (median, range); EF, ejection fraction; RVEDV, right ventricular end-diastolic volume; RVESV, right ventricular end-systolic volume; RVSV, right ventricular stroke volume; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVSV, left ventricular stroke volume; PI, pulmonary insufficiency; MPA, main pulmonary artery